Lucyna Wozniak

Prof. Dr. Lucyna Wozniak

orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
Marzena WojcikMarzena Wojcik
Marzena Wojcik
IBIzabela Burzyńska-Pędziwiatr
Izabela Burzyńska-Pędziwiatr
LWLucyna Wozniak
Lucyna Wozniak
Reactive oxygen species (ROS) generated in the presence of O2 by mitochondria, phagocytic cells, peroxisomes, and cytochrome P450 enzymes under physiological conditions, may play a dual function in the human organism. On the one hand, they participate in cell signal transduction cascades, leading to the activation of some transcription factors responsible for regulating of the expression of genes relevant for cell growth and differentiation. On the other hand, they cause oxidative damage of cellular DNA, protein and lipids, resulting in the initiation or development of numerous diseases such as cancer, cardiovascular diseases, type 2 diabetes mellitus, cataract, rheumatoid arthritis, or different neurodegenerative diseases. Both endogenous compounds (glutathione, ubiquinol, urate, bilirubin) and enzymes (superoxide dismutase, catalase, glutathione peroxidase) are engaged in the detoxification of ROS. In addition, numerous dietary components such as vitamin C, vitamin E, carotenoids, and polyphenols are thought to be involved in the antioxidant defense system. The present review article is focused on the summary and the assessment of research on the impact of dietary antioxidants in the prevention of chronic diseases, particularly cancer and cardiovascular diseases.

6 October 2008 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Closed access
PDF file
AZAndrzej Zieleniak
Andrzej Zieleniak
Marzena WojcikMarzena Wojcik
Marzena Wojcik
LWLucyna Wozniak
Lucyna Wozniak
The peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor superfamily. To date, three different PPAR isotypes, namely PPAR-α, -δ, and -γ, have been identified in vertebrates and have distinct patterns of tissue distribution. Like all nuclear receptors, the human PPAR-γ (hPPAR-γ) is characterized by a modular structure composed of an N-terminal A/B domain, a DNA-binding domain with two zinc fingers (C domain), a D domain, and a C-terminal ligand-binding domain (E/F domain). Human PPAR-γ exists in two protein isoforms, hPPAR-γ1 and -γ2, with different lengths of the N-terminal. The hPPAR-γ2 isoform is predominantly expressed in adipose tissue, whereas hPPAR-γ1 is relatively widely expressed. Human PPAR-γ plays a critical physiological role as a central transcriptional regulator of both adipogenic and lipogenic programs. Its transcriptional activity is induced by the binding of endogenous and synthetic lipophilic ligands, which has led to the determination of many roles for PPAR-γ in pathological states such as type 2 diabetes, atherosclerosis, inflammation, and cancer. Of the synthetic ligands, the thiazolidinedione class of insulin-sensitizing drugs (ciglitazone, pioglitazone, troglitazone, rosiglitazone) is employed clinically in patients with type 2 diabetes.

17 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
MKMichał Szymon Krawczyk
Michał Szymon Krawczyk
IBIzabela Burzyńska-Pędziwiatr
Izabela Burzyńska-Pędziwiatr
LWLucyna Wozniak
Lucyna Wozniak
Małgorzata Bukowiecka-MatusiakMałgorzata Bukowiecka-Matusiak
Małgorzata Bukowiecka-Matusiak
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycaemia and oxidative stress. Oxidative stress plays a crucial role in the development and progression of diabetes and its complications. Nutritional antioxidants derived from dietary sources have gained significant attention due to their potential to improve antidiabetic therapy. This review will delve into the world of polyphenols, investigating their origins in plants, metabolism in the human body, and relevance to the antioxidant mechanism in the context of improving antidiabetic therapy by attenuating oxidative stress, improving insulin sensitivity, and preserving β-cell function. The potential mechanisms of, clinical evidence for, and future perspectives on nutritional antioxidants as adjuvant therapy in diabetes management are discussed.

2 April 2020 in Expert Review of Proteomics
Verified
Journal Article
Open access
AGAlain Van Gool
Alain Van Gool
FCFernando Corrales
Fernando Corrales
MČMirjana Čolović
Mirjana Čolović
DKDanijela Krstić
Danijela Krstić
BOBegona Oliver-Martos
Begona Oliver-Martos
EAEda Aydindogan
Eda Aydindogan
Introduction: The importance of biomarkers for pharmaceutical drug development and clinical diagnostics is more significant than ever in the current shift toward personalized medicine. Biomarkers have taken a central position either as companion markers to support drug development and patient selection, or as indicators aiming to detect the earliest perturbations indicative of disease, minimizing therapeutic intervention or even enabling disease reversal. Protein biomarkers are of particular interest given their central role in biochemical pathways. Hence, capabilities to analyze multiple protein biomarkers in one assay are highly interesting for biomedical research. Areas covered: We here review multiple methods that are suitable for robust, high throughput, standardized, and affordable analysis of protein biomarkers in a multiplex format. We describe innovative developments in immunoassays, the vanguard of methods in clinical laboratories, and mass spectrometry, increasingly implemented for protein biomarker analysis. Moreover, emerging techniques are discussed with potentially improved protein capture, separation, and detection that will further boost multiplex analyses. Expert commentary: The development of clinically applied multiplex protein biomarker assays is essential as multi-protein signatures provide more comprehensive information about biological systems than single biomarkers, leading to improved insights in mechanisms of disease, diagnostics, and the effect of personalized medicine.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
Marzena WojcikMarzena Wojcik
Marzena Wojcik
MKMichał Szymon Krawczyk
Michał Szymon Krawczyk
PWPawel Wojcik
Pawel Wojcik
KCKatarzyna Cypryk
Katarzyna Cypryk
LWLucyna Wozniak
Lucyna Wozniak
The growing prevalence of age‐related diseases, especially type 2 diabetes mellitus (T2DM) and cancer, has become global health and economic problems. Due to multifactorial nature of both diseases, their pathophysiology is not completely understood so far. Compelling evidence indicates that increased oxidative stress, resulting from an imbalance between production of reactive oxygen species (ROS) and their clearance by antioxidant defense mechanisms, as well as the proinflammatory state contributes to the development and progression of the diseases. Curcumin (CUR; diferuloylmethane), a well‐known polyphenol derived from the rhizomes of turmeric Curcuma longa, has attracted a great deal of attention as a natural compound with beneficial antidiabetic and anticancer properties, partly due to its antioxidative and anti‐inflammatory actions. Although this polyphenolic compound is increasingly being recognized for its growing number of protective health effects, the precise molecular mechanisms through which it reduces diabetes‐ and cancer‐related pathological events have not been fully unraveled. Hence, CUR is the subject of intensive research in the fields Diabetology and Oncology as a potential candidate in the treatment of both T2DM and cancer, particularly since current therapeutic options for their treatment are not satisfactory in clinics. In this review, we summarize the recent progress made on the molecular targets and pathways involved in antidiabetic and anticancer activities of CUR that are responsible for its beneficial health effects.

1 March 1999 in Tetrahedron Letters
Verified
Journal Article
Closed access
LWLucyna Wozniak
Lucyna Wozniak
WSWojciech J. Stec
Wojciech J. Stec